Matches in SemOpenAlex for { <https://semopenalex.org/work/W1540223602> ?p ?o ?g. }
- W1540223602 endingPage "581" @default.
- W1540223602 startingPage "571" @default.
- W1540223602 abstract "J Clin Hypertens (Greenwich) . 2011;13:571–581. ©2011 Wiley Periodicals, Inc. Initial multiple drug therapy for hypertension achieves greater and quicker reductions and higher blood pressure (BP) control rates than monotherapy. This 8‐week, prospective, multicenter, randomized, double‐blind study compared the efficacy and safety of the initial combination of aliskiren/amlodipine with amlodipine monotherapy in African Americans with stage 2 hypertension. After a 1‐ to 4‐week washout, patients received aliskiren/amlodipine 150/5 mg or amlodipine 5 mg for 1 week and then were force‐titrated to aliskiren/amlodipine 300/10 mg or amlodipine 10 mg for 7 weeks. At week 8, greater reductions in mean sitting systolic BP were obtained with aliskiren/amlodipine (n=220) than with amlodipine (n=223) (least squares mean change [standard error of the mean], −34.1 [1.14] mm Hg vs −28.9 [1.12] mm Hg; P <.001). Ambulatory and central BP measures were consistent with clinic BP findings, although these were conducted in a small subset of patients (n=94 in ambulatory BP monitoring substudy and n=136 for central BP). More patients achieved goal BP (<140/90 mm Hg) with aliskiren/amlodipine than with amlodipine at week 8 (57.3% vs 48.0%; P = .051). Both treatment groups had similar adverse event rates (35.0% and 32.7%, respectively). The most common adverse events were peripheral edema (7.7% with aliskiren/amlodipine and 9.0% with amlodipine), headache, fatigue, and nausea. The combination of aliskiren/amlodipine reduced peripheral, ambulatory, and central BP more than amlodipine alone with similar tolerability in African Americans with stage 2 hypertension." @default.
- W1540223602 created "2016-06-24" @default.
- W1540223602 creator A5002458693 @default.
- W1540223602 creator A5008146428 @default.
- W1540223602 creator A5029510477 @default.
- W1540223602 creator A5034377530 @default.
- W1540223602 creator A5042772507 @default.
- W1540223602 creator A5045527630 @default.
- W1540223602 creator A5086518163 @default.
- W1540223602 creator A5087570461 @default.
- W1540223602 date "2011-06-20" @default.
- W1540223602 modified "2023-10-16" @default.
- W1540223602 title "Comparative Efficacy and Safety of Combination Aliskiren/Amlodipine and Amlodipine Monotherapy in African Americans With Stage 2 Hypertension" @default.
- W1540223602 cites W1988144405 @default.
- W1540223602 cites W2006884514 @default.
- W1540223602 cites W2014661179 @default.
- W1540223602 cites W2023912847 @default.
- W1540223602 cites W2027617419 @default.
- W1540223602 cites W2038409672 @default.
- W1540223602 cites W2044170646 @default.
- W1540223602 cites W2049037359 @default.
- W1540223602 cites W2072734363 @default.
- W1540223602 cites W2093723695 @default.
- W1540223602 cites W2105582798 @default.
- W1540223602 cites W2105944519 @default.
- W1540223602 cites W2106982105 @default.
- W1540223602 cites W2108819018 @default.
- W1540223602 cites W2114369401 @default.
- W1540223602 cites W2118772456 @default.
- W1540223602 cites W2121332703 @default.
- W1540223602 cites W2128343930 @default.
- W1540223602 cites W2129991662 @default.
- W1540223602 cites W2135326848 @default.
- W1540223602 cites W2139692142 @default.
- W1540223602 cites W2143954917 @default.
- W1540223602 cites W2160801689 @default.
- W1540223602 cites W2161490522 @default.
- W1540223602 cites W2164834486 @default.
- W1540223602 cites W2165730407 @default.
- W1540223602 cites W2171146813 @default.
- W1540223602 cites W2171818587 @default.
- W1540223602 cites W2172164753 @default.
- W1540223602 cites W2200489226 @default.
- W1540223602 cites W2303651371 @default.
- W1540223602 cites W4238251256 @default.
- W1540223602 cites W44463084 @default.
- W1540223602 doi "https://doi.org/10.1111/j.1751-7176.2011.00483.x" @default.
- W1540223602 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21806767" @default.
- W1540223602 hasPublicationYear "2011" @default.
- W1540223602 type Work @default.
- W1540223602 sameAs 1540223602 @default.
- W1540223602 citedByCount "20" @default.
- W1540223602 countsByYear W15402236022012 @default.
- W1540223602 countsByYear W15402236022013 @default.
- W1540223602 countsByYear W15402236022014 @default.
- W1540223602 countsByYear W15402236022016 @default.
- W1540223602 countsByYear W15402236022017 @default.
- W1540223602 countsByYear W15402236022018 @default.
- W1540223602 countsByYear W15402236022019 @default.
- W1540223602 countsByYear W15402236022022 @default.
- W1540223602 crossrefType "journal-article" @default.
- W1540223602 hasAuthorship W1540223602A5002458693 @default.
- W1540223602 hasAuthorship W1540223602A5008146428 @default.
- W1540223602 hasAuthorship W1540223602A5029510477 @default.
- W1540223602 hasAuthorship W1540223602A5034377530 @default.
- W1540223602 hasAuthorship W1540223602A5042772507 @default.
- W1540223602 hasAuthorship W1540223602A5045527630 @default.
- W1540223602 hasAuthorship W1540223602A5086518163 @default.
- W1540223602 hasAuthorship W1540223602A5087570461 @default.
- W1540223602 hasBestOaLocation W15402236021 @default.
- W1540223602 hasConcept C126322002 @default.
- W1540223602 hasConcept C126894567 @default.
- W1540223602 hasConcept C149323552 @default.
- W1540223602 hasConcept C164705383 @default.
- W1540223602 hasConcept C197934379 @default.
- W1540223602 hasConcept C198710026 @default.
- W1540223602 hasConcept C2777482430 @default.
- W1540223602 hasConcept C2779646130 @default.
- W1540223602 hasConcept C2779838083 @default.
- W1540223602 hasConcept C35785553 @default.
- W1540223602 hasConcept C71924100 @default.
- W1540223602 hasConcept C84393581 @default.
- W1540223602 hasConceptScore W1540223602C126322002 @default.
- W1540223602 hasConceptScore W1540223602C126894567 @default.
- W1540223602 hasConceptScore W1540223602C149323552 @default.
- W1540223602 hasConceptScore W1540223602C164705383 @default.
- W1540223602 hasConceptScore W1540223602C197934379 @default.
- W1540223602 hasConceptScore W1540223602C198710026 @default.
- W1540223602 hasConceptScore W1540223602C2777482430 @default.
- W1540223602 hasConceptScore W1540223602C2779646130 @default.
- W1540223602 hasConceptScore W1540223602C2779838083 @default.
- W1540223602 hasConceptScore W1540223602C35785553 @default.
- W1540223602 hasConceptScore W1540223602C71924100 @default.
- W1540223602 hasConceptScore W1540223602C84393581 @default.
- W1540223602 hasIssue "8" @default.
- W1540223602 hasLocation W15402236021 @default.
- W1540223602 hasLocation W15402236022 @default.
- W1540223602 hasLocation W15402236023 @default.